Patents
Patents for C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
08/2002
08/15/2002WO2002030860A3 Ketone compounds and compositions for cholesterol management and related uses
08/15/2002US20020111374 Estrogen receptor modulators
08/15/2002US20020111273 Insecticides, fungicides, miticides, plant safening agents
08/14/2002EP0724435B1 Amidino derivatives useful as nitric oxide synthase inhibitors
08/14/2002CN1364160A Isoxazolyl-and isoxazolinyl-substituted benzoylcyclohexanediones, production method and use thereof as herbicides and plant growth regulators
08/13/2002US6432994 Cardiovascular disorders, glaucoma; antiinflammatory, wound healing, hypotensive, antiasthmatic, and antianaphylactic agents
08/13/2002US6432949 Amide derivatives useful as inhibitors of the production of cytokines
08/13/2002CA2060573C N-(aryloxyalkyl)heteroaryl-8-azabicyclo¬3.2.1|octanes, intermediates and a process for the preparation thereof and their use as medicaments
08/08/2002WO2002006189A3 Aniline derivatives
08/08/2002WO2001085664A3 Compounds and methods for regulating bacterial growth and pathogenesis
08/08/2002US20020107253 Novel 4,5,-dihydroisoxazolylalkylpiperazine derivatives having selective biological activity at dopamine D3 or D4 receptor, and preparation thereof
08/08/2002CA2672805A1 Pyrimidine derivatives
08/07/2002EP1228760A2 5-membered heterocycle derivatives, production thereof and use thereof as medicaments
08/06/2002US6429317 Indane derivatives for antipsychotic compositions
08/01/2002WO2002058698A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
08/01/2002WO2002058690A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
08/01/2002CA2735478A1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
08/01/2002CA2735267A1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
07/2002
07/31/2002EP1226131A2 Isoxazolecarboxamide derivatives
07/31/2002EP1225896A1 Isoxazole derivatives to be used as phosphodiesterase vii inhibitors
07/25/2002WO2002015884A3 Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor
07/24/2002EP1223933A2 5-membered heterocycle derivatives, production thereof and use thereof as medicaments
07/24/2002EP1102743B1 Amide derivatives which are useful as cytokine inhibitors
07/24/2002EP0684945B1 Pyrazole- or isoxazole-substituted alkyl amide acat inhibitors
07/24/2002CN1360573A Phthalamide derivs., intermediates in production thereof, and agricultural/horticultural insecticides and method of using same
07/24/2002CN1360570A Phenyl sulfamate derivs.
07/24/2002CN1088061C Dihalopropene compounds, insecticidal/acaricidal agent contg. same, and intermediates
07/23/2002US6423717 Nervous system disorders
07/18/2002US20020094984 Novel isoxazolinone antibacterial agents
07/18/2002US20020094978 Novel isoxazoline fibrinogen receptor antagonists
07/17/2002EP1223167A2 Substituted isoxazoles for the treatment of inflammation
07/16/2002US6420567 Prodrugs
07/16/2002US6420396 Biphenyl and biphenyl-analogous compounds as integrin antagonists
07/16/2002US6420390 Heteroarylpiperidines and their use as antipsychotics
07/16/2002US6420363 Mono- or polyenic carboxylic acid derivatives
07/16/2002US6420349 Potent antibiotic active against gram-positive bacteria; animal feed;food preservatives; waterbased paints; white water of paper mills; disinfectants for medical and dental equipment
07/16/2002CA2056044C 4 benzoyl isoxazole derivatives
07/11/2002WO2002024632A3 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
07/11/2002US20020091272 Sulfonamides and derivatives thereof that modulate the activity of endothelin
07/11/2002US20020091270 Sulfonamides containing oxazole and substituted thiophene rings, useful for treating hypertension, cardiovascular disease, asthma, pulmonary hypertension, inflammatory diseases, vision defects, menstrual disorders, renal failure
07/11/2002US20020091089 (Substituted)acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases
07/10/2002EP0734380B1 4-benzoylisoxazoles and their use as herbicides
07/10/2002CN1358173A Heterocyclic dicarboxylic acid diamide derivatives, agricul-horticul tural insecticides and method of using the same
07/10/2002CN1357544A Prepn. of 5-methyl-3-isooxazolyl methyl formate
07/10/2002CN1357543A Sulfamethoxazole decoloring and refining process with sulfur dioxide and carbamide
07/10/2002CN1087290C 4-aminotetrahydrobenzisoxazole or-isothiazole compounds
07/09/2002US6417200 Antithrombotic agents
07/09/2002US6417178 Amyloid binding nitrogen-linked compounds for the antemortem diagnosis of alzheimer's disease, in vivo imaging and prevention of amyloid deposits
07/04/2002WO2002005848A3 Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders
07/04/2002US20020086985 Fluorescent dye for use in the detection of preferential compounds
07/04/2002DE10063294A1 New N-(heterocyclyl-alkyl)-fused norbornylamine derivatives, are NHE3 inhibitors useful e.g. for treating respiratory disorders, renal failure, intestinal dysfunction, lipid metabolism disorders or proliferative diseases
07/03/2002EP1218336A2 Melanin concentrating hormone antagonist
07/03/2002CN1356983A Tri-aryl acid derivatives as PPAR receptor ligands
07/02/2002US6414004 3-substituted 5-aryl-4-isoxazolecarbonitriles having antiviral activity
07/02/2002US6413997 3-(substituted phenyl)-5-(substituted heterocyclyl)-1,2,4-triazole compounds
07/02/2002US6413965 Selective cox-2 and an aldose reductase inhibitor; neuropathy, nephropathy, retinopathy and cardiomyopathy; avoiding side effects such as gastric and renal toxicity
06/2002
06/27/2002WO2002050045A1 Antiviral agents
06/27/2002CA2431483A1 Antiviral agents
06/26/2002EP1216980A1 Carboxylic acid derivatives and drugs containing the same
06/26/2002EP1216244A1 Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as d 4? antagonists
06/26/2002EP1216223A1 Novel dicarboxylic acid derivatives with pharmaceutical properties
06/26/2002EP1216125A1 A homogenization enhancing thermoplastic foam extrusion screw
06/25/2002US6410586 Modulators of protein tyrosine phosphatases (PTPases)
06/25/2002US6410566 Cyclic amine derivatives and their use as drugs
06/20/2002WO2002048124A2 Piperazine derivatives
06/20/2002WO2002048100A2 Thiosulphonic s-esters as material protective agent
06/20/2002WO2002022567A8 Novel thio derivatives of sordarin as antifungal agents
06/20/2002WO2001064755A3 Isoxazole gegen virale erkrankungen
06/20/2002WO2001014576A8 Process and intermediates for the preparation of isoxazolecaroxamides and analogues
06/20/2002US20020077485 Stable dissolution profile
06/20/2002US20020077316 For therapy and prophylaxis of cardiovascular disease, dyslipidemia; dyslipoproteinemia; disorder of glucose metabolism; Alzheimer's Disease; Syndrome X; peroxisome proliferator activated receptor-associated disorder
06/19/2002EP1214317A1 Antiviral agents
06/19/2002EP1214316A1 Five membered-ring compounds and utilization thereof in liquid crystal mixtures
06/19/2002EP1214305A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of inflammation
06/19/2002EP1214304A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes
06/19/2002EP1214294A1 Process for preparing substituted cyclopentane derivatives and novel crystalline structures thereof
06/19/2002CN1086387C N-(aryloxyalkyl)heteroarylpiperidines and heteroarylpiperazines, their preparing method and their use as medicine
06/18/2002CA1341370C Fused polycyclic compounds, methods of manufacture, and their use as paf antagonists, antihistamines and/or antiinflammatory agents
06/13/2002WO2002000651A3 Factor xa inhibitors
06/13/2002WO2001083438A3 New gamma selective retinoids
06/13/2002US20020071857 Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor
06/12/2002EP1212309A1 Caspase inhibitor
06/12/2002EP1212302A1 Compounds and pharmaceutical compositions as cathepsin s inhibitors
06/12/2002EP0889879B1 Butadiene derivatives and process for preparing thereof
06/12/2002CN1353690A Bradykinin receptor antagonists
06/06/2002US20020068719 Synergy between low molecular weight heparin and platelet aggregation inhibitors, providing a combination therapy for the prevention and treatment of various thromboembolic disorders
06/05/2002EP0711282B1 Compounds as pde iv and tnf inhibitors
06/04/2002USRE37729 Useful as antipsychotic and analgesic agents.
06/04/2002US6399784 Efficient method for the conversion of nitriles to amidines
05/2002
05/30/2002WO2002042282A1 Method for producing nitro-dihydroisoxazoles
05/30/2002WO2002042273A2 Acid derivatives useful as serine protease inhibitors
05/30/2002US20020065283 Heteroarylcarboxamide compounds active against protein tyrosine kinase related disorders
05/30/2002CA2428191A1 Acid derivatives useful as serine protease inhibitors
05/29/2002EP1208091A1 Benzophenones as inhibitors of reverse transcriptase
05/29/2002CN1085667C Substituted tetracylic azepine derivatives having affinity for 5-HT2 receptors
05/23/2002WO2002040458A1 Isoxazole derivatives
05/23/2002WO2002040009A1 Gaba enhancers in the treatment of diseases relating to reduced neurosteroid activity
05/23/2002WO2002006213A3 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
05/23/2002WO2001041760A9 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
05/23/2002US20020061930 Process for preparing substituted cyclopentane derivatives and novel crystalline structures thereof
1 ... 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 ... 115